AU2001242430A1 - Use of 2-phenylene diamine derivatives for the treatment of infections - Google Patents

Use of 2-phenylene diamine derivatives for the treatment of infections

Info

Publication number
AU2001242430A1
AU2001242430A1 AU2001242430A AU4243001A AU2001242430A1 AU 2001242430 A1 AU2001242430 A1 AU 2001242430A1 AU 2001242430 A AU2001242430 A AU 2001242430A AU 4243001 A AU4243001 A AU 4243001A AU 2001242430 A1 AU2001242430 A1 AU 2001242430A1
Authority
AU
Australia
Prior art keywords
infections
treatment
phenylene diamine
heteroaryl
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242430A
Other languages
English (en)
Inventor
Hassan Jomaa
Martin Schlitzer
Jochen Wiesner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Jomaa Pharmaka GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka GmbH filed Critical Jomaa Pharmaka GmbH
Publication of AU2001242430A1 publication Critical patent/AU2001242430A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
AU2001242430A 2000-02-24 2001-02-22 Use of 2-phenylene diamine derivatives for the treatment of infections Abandoned AU2001242430A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10008522A DE10008522A1 (de) 2000-02-24 2000-02-24 Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen
DE10008522 2000-02-24
PCT/EP2001/002016 WO2001062709A2 (de) 2000-02-24 2001-02-22 Verwendung von 2-phenylendiaminderivaten zur behandlung von infektionen

Publications (1)

Publication Number Publication Date
AU2001242430A1 true AU2001242430A1 (en) 2001-09-03

Family

ID=7632156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242430A Abandoned AU2001242430A1 (en) 2000-02-24 2001-02-22 Use of 2-phenylene diamine derivatives for the treatment of infections

Country Status (8)

Country Link
US (1) US20030036532A1 (ja)
EP (1) EP1257265B1 (ja)
JP (1) JP2004513067A (ja)
AT (1) ATE258048T1 (ja)
AU (1) AU2001242430A1 (ja)
CA (1) CA2401030A1 (ja)
DE (2) DE10008522A1 (ja)
WO (1) WO2001062709A2 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007831A2 (en) * 2003-07-18 2005-01-27 Vanderbilt University Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like
BRPI0415766A (pt) * 2003-10-22 2006-12-26 Council Of Scientifc & Ind Res uso de selecionados complexos zinco-aminoácido como anti-malarial
EP1939180A1 (en) 2006-12-20 2008-07-02 sanofi-aventis Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
WO2008110351A2 (en) * 2007-03-15 2008-09-18 Dompe' Pha.R.Ma S.P.A. Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents
AU2007100477B4 (en) * 2007-06-05 2007-07-05 Jurox Pty Ltd Parasiticide Composition
CN102666488B (zh) * 2010-01-05 2015-04-22 埃科特莱茵药品有限公司 作为抗疟疾剂的哌嗪类
CN102304094B (zh) * 2011-09-23 2014-03-26 常熟市南湖实业化工有限公司 一种周效磺胺及其中间体的制备方法
CN114644560B (zh) * 2022-04-20 2024-02-02 朗捷睿(苏州)生物科技有限公司 一种苯基丙烯酸类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0765313B1 (en) * 1994-06-17 2003-08-20 F. Hoffmann-La Roche Ag N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials

Also Published As

Publication number Publication date
DE10008522A1 (de) 2001-09-06
JP2004513067A (ja) 2004-04-30
CA2401030A1 (en) 2001-08-30
EP1257265B1 (de) 2004-01-21
WO2001062709A3 (de) 2002-04-18
WO2001062709A2 (de) 2001-08-30
ATE258048T1 (de) 2004-02-15
EP1257265A2 (de) 2002-11-20
US20030036532A1 (en) 2003-02-20
DE50101360D1 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
NO20054329L (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
TW200500362A (en) 5-membered heteroaromatic ring compound and pharmaceutical use thereof
SE0104140D0 (sv) Novel Compounds
SE0102438D0 (sv) New compounds
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
WO2003097656A3 (en) Novel substituted sulfamate anticonvulsant derivatives
SE0202133D0 (sv) Novel compounds
SE0102616D0 (sv) Novel compounds
GEP20063938B (en) Hepatitis c virus inhibitors
ATE338461T1 (de) Pyrazolpyrimidinfungizide
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
GEP20084284B (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
DE60001586D1 (de) Diphenyl-piperidin derivate
ATE424384T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
HUP0300370A2 (hu) Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20061045L (no) Imidazolderivater
MXPA04006041A (es) Antivirales de piridoquinoxalina.